Nukkleus Stock Analysis

NUKK Stock  USD 1.67  0.08  4.57%   
Nukkleus is fairly valued with Real Value of 1.69 and Hype Value of 1.79. The main objective of Nukkleus stock analysis is to determine its intrinsic value, which is an estimate of what Nukkleus is worth, separate from its market price. There are two main types of Nukkleus' stock analysis: fundamental analysis and technical analysis.
The Nukkleus stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nukkleus. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
For more information on how to buy Nukkleus Stock please use our How to buy in Nukkleus Stock guide.

Nukkleus Stock Analysis Notes

About 35.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.69. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Nukkleus recorded a loss per share of 19.36. The entity had not issued any dividends in recent years. The firm had 1:8 split on the 24th of October 2024. Nukkleus Inc., a financial technology company, focuses on providing software and technology solutions for retail foreign exchange trading industry worldwide. Nukkleus Inc. operates as a subsidiary of Global Elite Holdings Ltd. Nukkleus operates under SoftwareApplication classification in the United States and is traded on OTC Exchange. It employs 12 people. To find out more about Nukkleus contact Emil Assentato at 212-791-4663 or learn more at https://www.nukk.com.

Nukkleus Quarterly Total Revenue

175,214

Nukkleus Investment Alerts

Nukkleus generated a negative expected return over the last 90 days
Nukkleus has high historical volatility and very poor performance
Nukkleus may become a speculative penny stock
Nukkleus was previously known as Brilliant Acquisition Corp and was traded on NASDAQ Exchange under the symbol BRLI.
Nukkleus currently holds 3.65 M in liabilities. Nukkleus has a current ratio of 0.22, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Nukkleus' use of debt, we should always consider it together with its cash and equity.
The entity reported the previous year's revenue of 16.22 M. Net Loss for the year was (11.85 M) with loss before overhead, payroll, taxes, and interest of (661.4 K).
Nukkleus has a poor financial position based on the latest SEC disclosures
About 35.0% of the company outstanding shares are owned by corporate insiders
Latest headline from news.google.com: Nukkleus Inc. issues new shares to single investor By Investing.com - Investing.com

Nukkleus Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.43 M.

Nukkleus Profitablity

The company has Profit Margin (PM) of (2.53) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (7.94) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $7.94.
Last ReportedProjected for Next Year
Return On Tangible Assets(1.41)(1.48)
Return On Capital Employed(1.18)(1.12)
Return On Assets(0.79)(0.83)
Return On Equity(1.71)(1.62)

Management Efficiency

Nukkleus has return on total asset (ROA) of (1.1502) % which means that it has lost $1.1502 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (7.4205) %, meaning that it created substantial loss on money invested by shareholders. Nukkleus' management efficiency ratios could be used to measure how well Nukkleus manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -1.48. Return On Capital Employed is expected to rise to -1.12 this year. Total Current Liabilities is expected to rise to about 9 M this year. Liabilities And Stockholders Equity is expected to rise to about 22.2 M this year
Last ReportedProjected for Next Year
Book Value Per Share 1.00  1.05 
Tangible Book Value Per Share 0.33  0.35 
Enterprise Value Over EBITDA(47.94)(50.34)
Price Book Value Ratio 48.78  51.21 
Price Fair Value 48.78  51.21 
Enterprise Value Multiple(47.94)(50.34)
Enterprise Value534.1 M273.9 M
Understanding the management dynamics of Nukkleus allows us to gauge its ability to sustain growth and profitability. This comprehensive analysis aids in determining the stock's value.
Operating Margin
(7.94)
Profit Margin
(2.53)
Beta
(0.32)
Return On Assets
(1.15)
Return On Equity
(7.42)

Technical Drivers

As of the 25th of November, Nukkleus secures the Risk Adjusted Performance of 0.0108, downside deviation of 9.12, and Mean Deviation of 7.49. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Nukkleus, as well as the relationship between them.

Nukkleus Price Movement Analysis

Execute Study
The output start index for this execution was eleven with a total number of output elements of fifty. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Nukkleus middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Nukkleus. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Nukkleus Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Nukkleus insiders, such as employees or executives, is commonly permitted as long as it does not rely on Nukkleus' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Nukkleus insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Nukkleus Outstanding Bonds

Nukkleus issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Nukkleus uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Nukkleus bonds can be classified according to their maturity, which is the date when Nukkleus has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Nukkleus Predictive Daily Indicators

Nukkleus intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Nukkleus stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Nukkleus Forecast Models

Nukkleus' time-series forecasting models are one of many Nukkleus' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Nukkleus' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Nukkleus Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Nukkleus prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Nukkleus shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Nukkleus. By using and applying Nukkleus Stock analysis, traders can create a robust methodology for identifying Nukkleus entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(0.18)(0.19)
Operating Profit Margin(0.18)(0.19)
Net Loss(0.18)(0.19)

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Nukkleus to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Watchlist Optimization Now

   

Watchlist Optimization

Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
All  Next Launch Module
When determining whether Nukkleus is a strong investment it is important to analyze Nukkleus' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nukkleus' future performance. For an informed investment choice regarding Nukkleus Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nukkleus. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
For more information on how to buy Nukkleus Stock please use our How to buy in Nukkleus Stock guide.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nukkleus. If investors know Nukkleus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nukkleus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(19.36)
Revenue Per Share
7.024
Quarterly Revenue Growth
(0.97)
Return On Assets
(1.15)
Return On Equity
(7.42)
The market value of Nukkleus is measured differently than its book value, which is the value of Nukkleus that is recorded on the company's balance sheet. Investors also form their own opinion of Nukkleus' value that differs from its market value or its book value, called intrinsic value, which is Nukkleus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nukkleus' market value can be influenced by many factors that don't directly affect Nukkleus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nukkleus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nukkleus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nukkleus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.